You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
通化金馬(000766.SZ)半年度淨利潤降14.95%至1.18億元
格隆匯 08-19 16:19

格隆匯8月19日丨通化金馬(000766.SZ)發佈2019年半年度報告,實現營業收入9.17億元,同比增長6.51%;歸屬於上市公司股東的淨利潤1.18億元,同比下降14.95%;歸屬於上市公司股東的扣除非經常性損益的淨利潤9764.98萬元,同比下降22.77%;基本每股收益0.12元。

受國家醫藥相關政策變化,導致銷售費用增幅較大及參股公司投資收益減少影響,營收同比增長6.51%,淨利潤同比下降14.95%。

報告期內,公司在新藥研發、中藥二次開發及中藥質量標準研究與提升、生產工藝驗證、技術創新管理體系建設、科研項目申報等方面開展了大量有效工作,不斷提升公司科技創新能力及水平。公司繼續推進化藥1.1類新藥琥珀八氫氨吖啶片III期臨牀試驗,報告期已入組病例240餘例。

基於工業大麻價值和市場形勢的分析,報告期公司圍繞工業大麻進行產業佈局。公司先後與吉林省農業科學院、通化市二道江區人民政府,及黑龍江省七台河市人民政府、黑龍江省科學院簽訂《工業大麻合作項目協議》,探索及拓展在工業大麻領域的育種、種植、提取、深加工方面的深度開發,實施工業大麻科技成果研發與轉化。為加快推動公司在工業大麻領域的佈局,公司投資設立了黑龍江聖泰漢麻科技有限公司,重點規劃發展工業大麻的種植業;投資設立了哈爾濱聖泰漢麻科技有限公司,主要目的是為了更好的利用聖泰生物的生產加工條件,使種植產品向深加工轉化,促進產業鏈的完整和延伸。工業大麻產業鏈佈局,可與公司現有的中成藥、生化藥、以及即將上市的治療阿爾茨海默綜合症的1.1類新藥可以形成協同效應,符合公司經營發展戰略需要,有利於拓寬公司的經營領域,促進公司可持續健康發展。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account